Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma

21 Aug 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Lung Cancer Diagnosis and Treatment
Share to Lung Cancer Treatments and Mutations

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23974272
DOI: 10.1007/s00432-013-1495-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinomaPMID 23974272Read ↗

Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.Semantic proximity Read ↗

Establishing an EGFR mutation screening service for non-small cell lung cancer – Sample quality criteria and candidate histological predictorsSemantic proximity Read ↗

Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.Semantic proximity Read ↗

Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline MutationsSemantic proximity Read ↗

Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.Semantic proximity Read ↗

Correlation between epidermal growth factor receptor mutation and histologic subtypes or characteristics of computed tomography findings in patients with resected pulmonary adenocarcinoma.Semantic proximity Read ↗

Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.Semantic proximity Read ↗

High-grade lung adenocarcinomas with micropapillary and/or solid patterns: a review.Semantic proximity Read ↗

Histology-Related Associations of ERCC1, RRM1, and TS Biomarkers in Patients with Non–Small-Cell Lung Cancer: Implications for TherapySemantic proximity Read ↗

Prognosis of epidermal growth factor receptor-mutated stage I lung adenocarcinoma with radiologically solid features.Semantic proximity Read ↗

Association of IASLC/ATS/ERS Histologic Subtypes of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutations in 320 Resected Cases.Semantic proximity Read ↗

Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.